Bioequivalence and Bioavailability Forum

Dear all,

the 5^th conference of

The Global Harmonisation Initiative

is planned for April 6–7, 2022 in Amsterdam, The Netherlands.

Sessions:

1. Statistical considerations for BE assessment in specific situations
   • 2-stage, adaptive and replicate design: a regulatory update after the discussions at GBHI 2
     
   • Modeling & Simulation
2. Fed vs fasting conditions in BE trials: current status and new insights
   
3. Equivalence assessment of topical products: product-dependent approaches
   
4. Bioequivalence evaluation of narrow therapeutic index (NTI) Drugs
   

---

Update: Postponed; new dates September 28 – 29, 2022. Website, Programme.
The early-bird registration ends on July 10, 2022.